Aims and Scope:

Human Virology & Retrovirology: Open Access (HVROA) stands as a prominent journal dedicated to advancing research in the fields of human virology and retrovirology, shining a light on the intricate workings of viral infections that impact humanity. With a steadfast commitment to scientific excellence, HVROA explores the complex biology, epidemiology, and pathogenesis of viral diseases, unravelling the mechanisms that underlie their transmission, progression, and potential treatments.

Encompassing a wide array of topics, HVROA delves into the multifaceted realm of viral infections, with particular emphasis on HIV/AIDS, viral hepatitis, and emerging viral diseases. By investigating the diverse array of viral pathogens that afflict human populations, the journal seeks to broaden our understanding of their dynamics, impact on public health, and potential interventions.

HVROA serves as an invaluable platform for esteemed researchers, scientists, and clinicians in the fields of virology and retrovirology to share their groundbreaking discoveries, profound insights, and extensive knowledge with the broader scientific community. By fostering collaboration and facilitating the exchange of ideas and expertise, the journal drives forward the frontiers of human virology, spurring innovation, and advancements in diagnostics, therapeutics, and preventive strategies.

Embracing a rigorous and meticulous approach, HVROA welcomes the submission of original research articles, comprehensive review papers, and informative case reports that significantly contribute to our collective understanding of human virology and retrovirology. Through a stringent peer-review process, guided by leading experts in the field, the journal ensures the highest standards of scientific rigor and integrity, establishing itself as a trusted source of knowledge and innovation.

HVROA recognizes the transformative power of open access, which allows unrestricted access to its published content, transcending geographical and institutional barriers. By democratizing knowledge, the journal empowers researchers, clinicians, and policymakers worldwide to engage with the latest advancements, diverse perspectives, and significant developments in the field of human virology. This inclusivity promotes global collaboration, fosters scientific dialogue, and accelerates progress towards understanding, preventing, and treating viral infections.

Moreover, HVROA acknowledges the profound societal impact of human virology and retrovirology. By shedding light on the intricate mechanisms of viral diseases, the journal contributes to the development of evidence-based public health strategies, aids in the identification of novel therapeutic targets, and supports efforts to eliminate or mitigate the burden of viral infections. HVROA also plays a crucial role in educating the broader community about the complexities of viral diseases, raising awareness, and dispelling misconceptions.

In summary, Human Virology & Retrovirology: Open Access (HVROA) stands as a beacon of scientific exploration, driving research, innovation, and collaboration in the fields of human virology and retrovirology. Through its comprehensive coverage, rigorous peer-review process, and commitment to open access, the journal facilitates the dissemination of knowledge, catalyzes scientific breakthroughs, and improves global health outcomes. By fostering a vibrant community of researchers and clinicians, HVROA paves the way for transformative advancements in understanding, preventing, and managing viral infections that profoundly impact human populations.

Classification:

1. Basic Virology
2. Basic Molecular Virology
3. Basic Immunology
4. Microscopy
5. Virus Replication
6. Viral Pathogenesis
7. Host-Viral Infections
8. Prevention of Viral Infections
9. Treatment of Viral Infections
10. Health
11. Safety and Infection Control
12. Serology Methods
13. Viral Taxonomy
14. Basic Epidemiology & Biostatistics
15. Vector Biology
16. Virological Methods
17. Analytical Methods
18. Virus/Antigen Detection
19. Antivirals & Vaccines
20. Virus-Cell Interaction
21. Veterinary and Agricultural Viruses
22. Viral Enteric Diseases & Cancers
23. Viral Hepatitis
24. Viral Respiratory Diseases
25. Viral Hemorrhagic Fevers
26. Viral Exanthematous Diseases
27. History of HIV/AIDS
28. Epidemiology of HIV/AIDS
29. Signs and symptoms
30. Structure and Genome of HIV
31. Subtypes of HIV
32. Diagnosis of HIV/AIDS
33. CDC Classification System for HIV Infection
34. HIV Disease Progression Rates
35. Management of HIV/AIDS
36. Prevention of HIV/AIDS
37. HIV/AIDS Research
38. Who Disease Staging System
39. Countries by AIDS Prevalence Rate
40. Circumcision and HIV
41. Economic Impact
42. Sex Education
43. HIV/AIDS Denialism
44. HIV Drug Resistance Database
45. HIV Superinfection
46. Super AIDS
47. AIDS Dementia Complex
48. Tuberculosis Coinfection
49. HIV-Associated Nephropathy
50. HIV-Associated Lipodystrophy
51. HIV-Associated Pruritus
52. Gay Bowel Syndrome
53. Diffuse Infiltrative Lymphocytosis Syndrome
54. AIDS Defining Clinical Condition
55. History of HIV/AIDS
56. Epidemiology of HIV/AIDS
57. Whoonga
58. Antiviral Therapy
59. Opportunistic Infections
60. Alternative Medicine
61. Retrovirus Structure
62. Retrovirus Mediated Vector-Host Interactions
63. Molecular Expression
64. Retroviral Therapy and Immunology
65. Development of Therapeutics and Vaccine Approaches
66. Retroviral Pathology and Epidemiology
67. Retroviral General and Molecular Physiology
68. Techniques and Tools for Analysis of Retrovirus
69. Retroviral Drugs and their Safety
70. Genetics of Retrovirus